PathMaker Neurosystems Announces Initiation of First-in-Human Trial in ALS for Non-Invasive Neuromodulation Device

BOSTON and PARIS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company ...

Related Keywords

Boston ,Massachusetts ,United States ,New York ,France ,Spaulding Rehabilitation Hospital ,Paris ,France General ,United Kingdom ,Sabrina Paganoni ,Nader Yaghoubi ,Zaghloul Ahmed ,Pathmaker Neurosystems ,Spaulding Neuromodulation Center At Rehabilitation Hospital ,City University Of New York ,Drug Administration ,College Of Staten Island ,National Institutes Of Health ,Integrative Rehabilitation Lab ,Muscular Dystrophy Association ,Department Of Physical Therapy ,Program In Neuroscience ,Research Fund ,Pathmaker Neurosystems Inc ,Maker Neurosystems ,Early Feasibility Study ,Leon Morales Quezada ,Research Associate Director ,Spaulding Neuromodulation Center ,Associate Professor ,Physical Medicine ,Massachusetts General ,Cullen Education ,National Institutes ,Massgeneralbrigham Rally ,Physical Therapy ,City University ,Staten Island ,